EP Device Registry

This study will provide ongoing, high quality data on the safety, performance, and clinical benefits of Abbott's EP devices in a real-world setting.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiac Rhythm Disorder Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Sex eligibility

All sexes

Study type

Observational

Primary location

KH Wiener Neustadt, Wiener Neustadt, Lower Austria, Austria

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subject underwent an electrophysiology imaging (diagnostic procedure) and/or ablation procedure that used one or more Abbott devices covered by this Registry.
Subject is willing and able to comply with the site's standard of care follow-up schedule.

Exclusion criteria

Subject is currently participating in another clinical investigation that may confound the results of this Registry.

Treatment and study plan

Standard of care

Other

Standard of care mapping and/or ablation

Primary outcomes

The proportion of patients with a device- and/or procedure-related Serious Adverse Event

Time frame: 7-days

that occurred within 7-days of the procedure.
The proportion of procedures that achieved acute success.

Time frame: Baseline

Sponsors and collaborators

Lead sponsor

Abbott Medical Devices

Industry

Registry information

Important dates

Study start: 2020
Primary completion: 2026
Study completion: 2026
First posted: Jul 7, 2020
Registry last updated: Mar 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed